|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3458100 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17705364.2 |
| Date of filing the European patent application | 2017-02-13 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-01 |
| (46) | Date of publication of the claims translation | 2020-08-25 |
| (86) | Number | PCT/EP2017/053157 |
| Date | 2017-02-13 |
| (87) | Number | WO 2017/137628 |
| Date | 2017-08-17 |
| (30) | Number | Date | Country code |
| 16155481 | 2016-02-12 | EP | |
| 16206761 | 2016-12-23 | EP |
| (72) |
COUMANS, Rudy Gerardus Elisabeth, NL
SPIJKER, Henri Johannes, NL
|
| (73) |
Byondis B.V.,
Microweg 22, 6545 CM Nijmegen,
NL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Selektyvus antikūnų su modifikuotu cisteinu mažinimas |
| SELECTIVE REDUCTION OF CYSTEINE-ENGINEERED ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-01-23 | 9 | 208.00 EUR |
| 2026-02-13 |